Bladder Cancer: Novartis Poised to Dominate Market as Targeted Agents Launch for Advanced Disease - On Demand

Based on our Niche Markets and Rare Diseases Bladder Cancer report, Decision Resources is offering this exclusive webinar presented by Decision Resources Analyst Mary Argent-Katwala, Ph.D.

Date & Time
Recorded live on Wednesday, February 29, 2012
10 a.m. ET, 4 p.m. CET

Click here to view the invite.

To learn how you can access the recorded playback of this event, please fill out the following form and a representative will contact you:


*First Name:
*Last Name:
 Title:
*Company:
 Phone:
*Country:
*Email Address:
 Comments:
*Agreement:
I have read and agree to abide by the Decision Resources Terms of Use and Privacy Policy.

*Required






Search Reports


Decision Resources Group brands include: